Malaria treatment and prevention. A review.
D000293:Adolescent; D000328:Adult; D000351:Africa, Eastern; D000962:Antimalarials / Q000008:administration & dosage / Q000494:pharmacology*; D001645:Biguanides / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D002738:Chloroquine; D004352:Drug Resistance, Microbial; D006801:Humans; D007223:Infant; D007226:Infant Mortality; D007231:Infant, Newborn; D008288:Malaria / Q000188:drug therapy* / Q000517:prevention & control*; D010961:Plasmodium / Q000472:pathogenicity; D010963:Plasmodium falciparum / Q000472:pathogenicity; D010965:Plasmodium malariae / Q000472:pathogenicity; D010966:Plasmodium vivax / Q000472:pathogenicity; D011796:Quinacrine / Q000627:therapeutic use; D011803:Quinine / Q000627:therapeutic use; D011804:Quinolines / Q000627:therapeutic use; D013449:Sulfonamides / Q000627:therapeutic use
D000962:Antimalarials; D001645:Biguanides; D011804:Quinolines; D013449:Sulfonamides; D002738:Chloroquine; D011803:Quinine; D011796:Quinacrine